Skip to main content

Table 1 Incidence of JAZF1/SUZ12 fusion transcript in uterine ESTs

From: JAZF1/SUZ12 gene fusion in endometrial stromal sarcomas

First author (year)

ESN +/total (%)

LG-ESS +/total (%)

UES +/total (%)

Normal endometrium +/total (%)

Total Nr. of analyzed ESTs

Informative for JAZF1/SUZ12 (%)

Koontz (2001) [3]

3/3 (100)

5/5 (100)

3/7 (43)

0/10 (0)

15

15 (100)

Micci (2003) [18]

-

1/4 (25)

-

-

4

4 (100)

Huang (2004) [6]

2/2 (100)

3/13 (23)

-

-

15

15 (100)

Hrzenjak (2005) [7]

-

16/20 (80)

0/2 (0)

0/10 (0)

22

22 (100)

Micci (2006) [36]

-

0/3 (0)

-

-

3

3 (100)

Oliva (2007) [10]

3/6 (50)

0/1 (0)

-

-

10

6 (60)

Nucci (2007) [8]

4/4 (100)

8/16 (50)

-

-

32

20 (63)

Kurihara (2008, 2010) [9, 12]

4/6 (67)

5/11 (45)

1/6 (17)

-

37

23 (62)

Li (2007) [33]

4/4 (100)

-

-

-

4

4 (100)

D'Angelo (2013) [37]

1/3 (33)

1/13 (8)

0/7 (0)

-

23

22 (96)

Isphording (2013) [45]

-

7/16 (44)

0/6 (0)

-

22

22 (100)

Total (%)

21/28 (75)

46/102 (45)

4/28 (14)

0/20 (0)

187

156 (83)

  1. Abbreviations: ESN endometrial stromal nodule, LG-ESS low-grade endometrial stromal sarcoma, UES undifferentiated endometrial sarcoma, + positive for JAZF1/SUZ12 gene fusion; total, number of all analyzed samples